BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 9:54:00 AM | Browse: 907 | Download: 626
Publication Name World Journal of Gastroenterology
Manuscript ID 1446
Country Greece
Received
2012-12-12 07:25
Peer-Review Started
2012-12-12 15:59
To Make the First Decision
2013-01-24 18:48
Return for Revision
2013-01-25 12:03
Revised
2013-02-08 06:05
Second Decision
2013-03-28 17:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-03-29 11:46
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-05-05 14:40
Publish the Manuscript Online
2013-06-04 12:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pathology
Manuscript Type Review
Article Title E2F transcription factors and digestive system malignancies: How much do we know?
Manuscript Source Invited Manuscript
All Author List Athanasios Xanthoulis and Dina G Tiniakos
Funding Agency and Grant Number
Funding Agency Grant Number
“Kapodistrias” Research Program
Special Accounts Research Fund 70/4/6549
National and Kapodistrian University of Athens, Greece
Corresponding Author Dina G Tiniakos, MD, PhD, Laboratory of Histology-Embryology, Medical School, National and Kapodistrian University of Athens, 75 M Asias street, 11527 Athens, Greece. dtiniak@med.uoa.gr
Key Words E2F; Colorectal cancer; Gastric cancer; Esophageal cancer; Pancreatic cancer; Hepatocellular carcinoma; Digestive system malignancies
Core Tip The E2F family of transcription factors has been in the focus of cancer research because its members regulate significant cellular functions related to cell cycle and apoptosis. E2Fs may act either as tumor-promoters or as tumor-suppressors, depending on the tissue. This review highlights the role of E2Fs in digestive system malignancies and their possible implication in diagnosis, treatment and prognosis.
Publish Date 2013-06-04 12:34
Citation Xanthoulis A, Tiniakos DG. E2F transcription factors and digestive system malignancies: How much do we know? World J Gastroenterol 2013; 19(21): 3189-3198
URL http://www.wjgnet.com/1007-9327/full/v19/i21/3189.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i21.3189
Full Article (PDF) WJG-19-3189.pdf
Manuscript File 1446-Review.doc
Answering Reviewers 1446-Answering reviewers.doc
Copyright License Agreement 1446-Copyright assignment.doc
Non-Native Speakers of English Editing Certificate 1446-Language cetificate.doc
Peer-review Report 1446-Peer review.pdf
Scientific Editor Work List 1446-Scientific editor work list.doc